Asset profile
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers …
Newest first.
| Registry ID | Phase | Status | Primary completion | Enrollment | Sites |
|---|---|---|---|---|---|
| NCT07368998 | Phase 2 | Recruiting | Oct 31, 2028 | 80 | 4 of 34 sites in the United States |
| NCT07245797 | Phase 2 | Not yet recruiting | Dec 15, 2026 | 164 | |
| NCT07441512 | Phase 2 | Not yet recruiting | Mar 15, 2028 | 26 | |
| NCT05862285 | Phase 3 | Recruiting | Mar 1, 2033 | 200 | 0 of 85 sites in the United States |
| NCT05332561 | Phase 2 | Recruiting | Mar 1, 2030 | 240 | 0 of 9 sites in the United States |
| NCT07748208 | Phase 2 | Recruiting | Jun 15, 2029 | 40 | 12 of 13 sites in the United States |
| NCT07405801 | Phase 2 | Recruiting | Dec 19, 2028 | 80 | 11 of 59 sites in the United States |
| NCT04802759 | Phase 1/2 | Recruiting | May 30, 2029 | 316 | 12 of 32 sites in the United States |
| NCT05708235 | Phase 2 | Active, not recruiting | Jun 30, 2028 | 976 | 0 of 41 sites in the United States |
| NCT05646862 | Phase 3 | Recruiting | Nov 13, 2026 | 420 | 39 of 210 sites in the United States |
| NCT07287150 | Phase 2 | Recruiting | Mar 31, 2028 | 100 | 7 of 50 sites in the United States |
| NCT07694973 | Phase 2 | Not yet recruiting | Jun 29, 2028 | 62 | 0 of 1 sites in the United States |
| NCT07522697 | Phase 2 | Not yet recruiting | May 1, 2030 | 48 | 0 of 1 sites in the United States |
| NCT04849364 | Phase 2 | Terminated | Oct 24, 2024 | 52 | 13 of 13 sites in the United States |
| NCT04551521 | Phase 2 | Completed | Dec 30, 2024 | 72 | 0 of 9 sites in the United States |
| NCT07323576 | Phase 2 | Withdrawn | Mar 1, 2029 | 0 |
Other drugs and candidates from the same company tracked in this sector.